As of 3:59pm ET
| +0.02 / +0.09%|
The 4 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 26.50, with a high estimate of 35.00 and a low estimate of 18.00. The median estimate represents a +21.95% increase from the last price of 21.73.
The current consensus among 4 polled investment analysts is to Hold stock in Enanta Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.